Global wound debridement products market is estimated to be valued at US$ 779.9 million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030).
Analysts’ Views on Global Wound Debridement Products Market:
Global wound debridement products market growth can be hindered by lack of awareness about the wound debridement management. For instance, in January, 2022, Scapa Healthcare, a U.S.-based wound dressing company, signed an exclusive technology licensing agreement with Synedgen Inc., a U.S.-based medical technology company, for novel wound care technology. Under the terms of this agreement, Scapa Healthcare will have exclusive rights over Synedgen Inc.’s glycopolymer technology in the field of dermal wounds and surgical care applications both over the counter and in the professional setting.
Figure 1. Global Wound Debridement Products Market Share (%), By Product Type, 2023
To learn more about this report, Request sample copy
Global Wound Debridement Products Market – Drivers
Increasing Collaborations among Key Market Players
Increasing adoption of inorganic strategies such as collaborations among key market players is expected to drive the global wound debridement products market over the forecast period. For instance, on March 8, 2023, Ceapro Inc., a Canada-based biotechnology company, announced that its study in collaboration with The Angiogenesis Foundation, non-profit organization in U.S., on Avena Sativa derived therapeutics β-Glucan and Avenanthramide was accepted for presentation at annual meeting of wound healing society held at Canada. It was found that oats (Avena Sativa) can accelerate wound healing in mice by anti-inflammatory mechanisms, and can reduce scar formation. It can stimulate angiogenesis.
Increasing Awarenss Programs by Key Market Players
In June 2021, Sanara MedTech Inc., a U.S.-based surgical and chronic wound care product provider company, announced a partnership with Pixalere Healthcare Inc., a Canada-based wound care software company, to advance its comprehensive wound and skin care strategy. The aim of this partnership is to use Pixalere’s technology including decision support, documentation, and wound tracking analytics, with complementary Sanara solutions that offer virtual access to expert wound and skin physicians, advanced diagnostics, and wound care product order fulfillment.
Figure 2. Global Wound Debridement Products Market Value (US$ Million), By Region, 2023
To learn more about this report, Request sample copy
Global Wound Debridement Products Market - Regional Analysis
Among region, North America is estimated to hold a dominant position in the global wound debridement products market over the forecast period. North America holds 56.5% of the market share over the forecast period due to increasing number of geriatric populationand increasing prevalence of diabetes . According to report spublished by the U.S. Centers for Disease Control & Prevention, on June 29, 2022, 37.3 million people in the U.S. had diabetes that is 11.3% of the total the U.S. population in 2021. Out of these, only 28.7 million people are diagnosed while 8.5 million cases were not even diagnosed thatis equivalent to 23.0% of adults. Cases of diabetic foot ulcers is present in total 2.4% of hospitalized patients. Overall rate of mortality is 13% and the incidences of limb amputation is nearly 25%.
Wound Debridement Products Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 779.9 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 to 2030 |
Forecast Period 2023 to 2030 CAGR: | 9.2% | 2030 Value Projection: | US$ 1,446.5 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, Human Biosciences Inc. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Wound Debridement Products Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems reagrding transportation of drugs from one place to another.
However, the COVID-19 pandemic had negative impact on the global debridement products market. For instance, according to data publsihed by the commonwealth fund on May 19, 2020, the number of patient visits to hospitals and ambulatory practices declined nearly 60% by the beginning of pandemic in April 2020. Even after pandemic, number of visits were roughly one third lower than what was before the pandemic.
Global Wound Debridement Products Market- Segmentation
Global wound debridement products market report is segmented into product type, application, end user, and region.
Based on Product Type, the market is segmented into hydrosurgical debridement devices, low frequency ultrasound devices, surgical wound debridement devices, mechanical debridement pads, traditional wound debridement devices, and larval therapy. Out of which, the low frequency ultrasound devices segment is expected to hold a dominant position in the global wound debridement products market during the forecast period due to increasing demand of ultrasound devices for wound debridement management.
Based on Application, the market is segmented into chronic ulcers, surgical wounds, traumatic wounds, and burn cases. Out of which, chronic ulcers segment is expected to hold a dominant position in the global wound debridement products market during the forecast period due to increasing prevalence of chronic ulcers among patients.
Based on End User, the market is segmented into hospitals, ambulatory surgical centers, specialized clinics, and others (nursing facilities, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing number of hospitals.
Based on Region, North America is to hold a dominant position in the global wound debridement products market during the forecast period due to increasing demand of wound debridement products in that region.
Among all segmentation, the product type segment has the highest potential due to increasing use of debridement products for the wound care managemnt
Global Wound Debridement Products Market- Cross Sectional Analysis
Among all the segments, surgical wound debridement devices hold dominat position in the global wound debridement products market. Thus, increasing numbers of geriatric patients, increasing cases of injuries and trauma and increasing product launches by key market players in different regions are expected to drive the market growth. For instance, in September, 2021, Human Biosciences Inc., a U.S. based biotechnology company, launched two wound care management products called Medifil and Skin Temp. These products helps to stop bleeding, and plays an important role in healing of wound.
Global Wound Debridement Products Market: Key Developments
Increasing Awareness Campaign by Local Health Department To Raise Awareness For Wound Care Management
Increasing awareness campaign by local health department to raise awareness for wound care management is expected to drive the market growth over the forecast period. For instance, in August 2022, The Far West Local Health District (LHD), the local health department, organized wound awareness week to raise awareness in the community of the impact of wounds and to improve awareness of chronic wounds and influence wound management policy.
Global Wound Debridement Products Market: Restraint
High Cost Associated With Wound Care Management
The high cost associated with wound care management with advanced wound dressing material, wound care devices, and bioactive products is expected to hinder the market growth over the forecast period. For instance, according to article published by International Wound Journal, in June 2020, the gross healthcare cost per patient ranges from US$ 15,789 –US$ 17,761. This adds the cost of surgical dressings that are required to change every day. Apart from this, the treatment formulation suggested by healthcare practitioner also adds up the cost. Depending on duration of treatment the cost increases.
Global Wound Debridement Products Market - Key Players
Major players operating in the global wound debridement products market include DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, and Human Biosciences Inc.
Definition: Wound debridement is the process of removing dead tissue from wounds. It is necessary to accelerate healing process of the remaining healthy tissue. Biological debridement, enzymatic debridement, autolytic debridement, and mechanical debridement are some of the types of wound debridement. Hydrotherapy, wet-to-dry dressing, and monofilament debridement pads are the types of mechanical debridement.
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients